Medicine for treating diabetes

A diabetes and drug technology, applied in the field of drugs for the treatment of diabetes, can solve the problems of no metabolic waste being excreted from the body, insignificant blood sugar lowering effect, limited curative effect, etc. amount of effect

Inactive Publication Date: 2012-05-02
施红
View PDF2 Cites 5 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] However, the drugs currently used to treat diabetes are only based on the function of nourishing yin, replenishing qi, activating blood circulation or the function of nourishing yin, replenishing qi, activating serum heat, and do not further excret

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Medicine for treating diabetes
  • Medicine for treating diabetes
  • Medicine for treating diabetes

Examples

Experimental program
Comparison scheme
Effect test

specific Embodiment approach 1

[0035] (1) A medicine for treating diabetes, characterized in that it comprises a medicine of group A with the function of nourishing yin, replenishing qi and activating blood circulation and a medicine of group C with the function of clearing the liver, promoting dampness and eliminating turbidity.

[0036]There are many kinds of medicines in the group C with the function of clearing the liver, promoting dampness and releasing turbidity, and one preferred embodiment is as follows: the medicines in group C with the function of clearing the liver, promoting dampness and releasing turbidity include the following raw materials in parts by weight: Capillaris 15-25 parts + Rhubarb 3-5 parts + Gardenia 8-12 parts + Talc 15-25 parts + Qumai 10-20 parts + Cucumber 10-20 parts + Plantago 10-20 parts + Tongcao 10- 15 parts + 6-8 parts of licorice + 6-8 parts of Bupleurum + 6-15 parts of schisandra.

[0037] There are many kinds of medicines in group A with the function of nourishing yin...

specific Embodiment approach 2

[0088] (1) A medicine for treating diabetes, characterized in that: it comprises a medicine of group B with the function of nourishing yin, replenishing qi, invigorating blood serum and heat, and a medicine of group C with the function of clearing the liver, promoting dampness and eliminating turbidity.

[0089] Wherein, for the composition of the drugs in Group C with the function of clearing the liver, promoting dampness and eliminating turbidity, please refer to the description in the first specific embodiment.

[0090] There are many kinds of group B drugs with the functions of nourishing yin, replenishing qi, activating serum heat, and one of the preferred embodiments is as follows: the group B drugs with functions of nourishing yin, replenishing qi, activating serum heat include the following raw materials in parts by weight: 10-20 parts of dendrobium + 20-50 parts of astragalus + 15-30 parts of salvia miltiorrhiza + 6-15 parts of schisandra + 10-30 parts of raw land + 10...

specific Embodiment approach 3

[0123] (1) A medicine for treating diabetes, characterized in that it comprises a medicine of group A with the function of nourishing yin, replenishing qi and activating blood circulation, a medicine of group B with the function of nourishing yin, replenishing qi and activating serum heat, and a medicine of group B with the function of clearing liver, promoting dampness and releasing turbidity. Functional Group C drugs.

[0124] Among them, for the composition of the drugs in group A with the function of nourishing yin, replenishing qi and activating blood circulation and the drugs in group C with the function of clearing liver, promoting dampness and purging turbidity, please refer to the description in Embodiment 1. For the composition, please refer to the description of the second specific embodiment.

[0125] (2) Embodiment

[0126] For specific preparation examples of preferred embodiments of Group A drugs with the function of nourishing yin, replenishing qi and activati...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to a medicine for treating diabetes, which is characterized by comprising group C medicines with effects of clearing liver, promoting diuresis and resolving turbidity. The group C medicines with the effects of clearing liver, promoting diuresis and resolving turbidity preferably consist of the following Chinese herbal medicines in part by weight: 15 to 25 parts of virgate wormwood herb, 3 to 5 parts of rhubarb, 8 to 12 parts of gardenia, 15 to 25 parts of talc, 10 to 20 parts of pink herb, 10 to 20 parts of polygonum aviculare, 10 to 20 parts of plantain seed, 10 to 15 parts of ricepaperplant pith, 6 to 8 parts of liquoric root, 6 to 8 parts of bupleurum and 6 to 15 parts of Chinese magnoliavine fruit. The medicine for treating diabetes can achieve the effect of reducing and stabilizing the blood sugar of patients with diabetes when matched with group A medicines with effects of nourishing yin, tonifying qi and activating blood and/or group B medicines with effects of nourishing yin, tonifying qi, activating blood and clearing heat.

Description

technical field [0001] The invention relates to a medicine for treating diabetes. Background technique [0002] Diabetic lesions involve multiple systems, organs, and levels in the body, and there are many late complications and coexisting diseases. Modern medical research believes that insulin resistance and decreased function of islet β cells are the two most important causes of type 2 diabetes. Evidence-based medical research shows that 10-15 years before the onset of type 2 diabetes, patients mainly present with insulin resistance, lipid metabolism disorder and macrovascular disease clinically. / L, PBG>11.1mmol / L) mainly manifests as decreased insulin function, small blood vessel and microangiopathy, and decreased sensitivity of the body to the hypoglycemic western medicines taken, gradually increasing blood sugar level or fluctuating blood sugar, blood lipid disorder, elevated blood pressure. [0003] The convenience and obvious hypoglycemic effect of oral hypogly...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K36/744A61K36/884A61K36/8888A61K36/8945A61K36/8962A61K36/8968A61K36/8984A61K36/899A61K36/9064A61K36/9068A61P3/10A61K31/045A61K33/06A61K33/12A61K35/56A61K35/586
Inventor 施红
Owner 施红
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap